Literature DB >> 12494944

Urinary tract infection in iNOS-deficient mice with focus on bacterial sensitivity to nitric oxide.

Mirjana Poljakovic1, Katarina Persson.   

Abstract

Inducible nitric oxide synthase (iNOS)-deficient mice were used to examine the role of iNOS in Escherichia coli-induced urinary tract infection (UTI). The toxicity of nitric oxide (NO)/peroxynitrite to bacteria and host was also investigated. The nitrite levels in urine of iNOS+/+ but not iNOS/ mice increased after infection. No differences in bacterial clearance or persistence were noted between the genotypes. In vitro, the uropathogenic E. coli 1177 was sensitive to 3-morpholinosydnonimine, whereas the avirulent E. coli HB101 was sensitive to both NO and 3-morpholinosydnonimine. E. coli HB101 was statistically (P < 0.05) more sensitive to peroxynitrite than E. coli 1177. Nitrotyrosine immunoreactivity was observed in infected bladders of both genotypes and in infected kidneys of iNOS+/+ mice. Myeloperoxidase, neuronal (n)NOS, and endothelial (e)NOS immunoreactivity was observed in inflammatory cells of both genotypes. Our results indicate that iNOS/ and iNOS+/+ mice are equally susceptible to E. coli-induced UTI and that the toxicity of NO to E. coli depends on bacterial virulence. Furthermore, myeloperoxidase and nNOS/eNOS may contribute to nitrotyrosine formation in the absence of iNOS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12494944     DOI: 10.1152/ajprenal.00101.2002

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  7 in total

1.  Is there a relationship between phosphodiesterase type 5 inhibitors and biochemical recurrence after radical prostatectomy: a systematic review and meta-analysis.

Authors:  Qing He; Bang-Hua Liao; Kai-Wen Xiao; Liang Zhou; Shi-Jian Feng; Hong Li; Kun-Jie Wang
Journal:  Int Urol Nephrol       Date:  2018-09-19       Impact factor: 2.370

2.  Tumor necrosis factor alpha- and inducible nitric oxide synthase-producing dendritic cells are rapidly recruited to the bladder in urinary tract infection but are dispensable for bacterial clearance.

Authors:  Daniel Engel; Ulrich Dobrindt; André Tittel; Petra Peters; Juliane Maurer; Ines Gütgemann; Brigitte Kaissling; William Kuziel; Steffen Jung; Christian Kurts
Journal:  Infect Immun       Date:  2006-09-11       Impact factor: 3.441

Review 3.  Waging war against uropathogenic Escherichia coli: winning back the urinary tract.

Authors:  Kelsey E Sivick; Harry L T Mobley
Journal:  Infect Immun       Date:  2009-11-16       Impact factor: 3.441

4.  Experimental supratrigonal cystectomy: II--Evaluation of urinary calculi, infection, and bladder dysfunction in the pathogenesis of renal failure.

Authors:  Milton Barros; Reinaldo Martinelli; Heonir Rocha
Journal:  Int Urol Nephrol       Date:  2008       Impact factor: 2.370

5.  Recurrent urinary tract infection and risk of bladder cancer in the Nijmegen bladder cancer study.

Authors:  S H Vermeulen; N Hanum; A J Grotenhuis; G Castaño-Vinyals; A G van der Heijden; K K Aben; I U Mysorekar; L A Kiemeney
Journal:  Br J Cancer       Date:  2014-11-27       Impact factor: 7.640

6.  Role of Hypoxia Inducible Factor-1α (HIF-1α) in Innate Defense against Uropathogenic Escherichia coli Infection.

Authors:  Ann E Lin; Federico C Beasley; Joshua Olson; Nadia Keller; Robert A Shalwitz; Thomas J Hannan; Scott J Hultgren; Victor Nizet
Journal:  PLoS Pathog       Date:  2015-04-30       Impact factor: 6.823

7.  Endothelial nitric oxide synthase limits host immunity to control disseminated Candida albicans infections in mice.

Authors:  Dhammika H Navarathna; Michail S Lionakis; David D Roberts
Journal:  PLoS One       Date:  2019-10-31       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.